Targeted HD Wipe Sampling with USP <800> Compliance – Safer Surfaces, Smarter Monitoring!

USP <800> states the following: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).

SOME RECOMMENDED AREAS to be sampled:

  • Front grille within the C-PEC
  • Cart beside the C-PEC
  • Passthrough
  • Floor in front of the C-PEC
  • Armrest of a patient treatment chair

HD Wipe Sampling

Groups of drugs Limit of detection
(ng per paper)
Group 1F
fluorouracil		 2
Group 1M
methotrexate		 1
Group 2
cytarabine
dacarbazine
DOXOrubicin
epirubicin
gemcitabine
melphalan		 2.5
0.5
10
10
0.5
1
Group 3
cyclophosphamide
DOCEtaxel
etoposide
ifosfamide
irinotecan
methotrexate
PACLitaxel
PEMEtrexed
topotecan
vinBLAStine
vinCRIstine		 0.5
30
2
0.5
2
1
10
2
1
5
5
Group 4
Platins: (CISplatin, oxaliplatin, CARBOplatin)		 0.5
Group 5
All hazardous drugs in groups 1 to 4		 0.5

 

  • Contribute to the assessment of safe practices in the workplace.
  • Evaluate potential HD exposure to staff (pharmacy, nursing, other personnel)
  • Validate the effectiveness of decontamination procedures.
  • Assess the level of compliance of current procedures.

Pricing

Select the group and multiply the price
by the number of swabs needed.

Group 1.............................Call for Pricing

Group 2, 3, or 4.................Call for Pricing

Group 5............................Call for Pricing

Sampling Kit..........INCLUDED FOR FREE

Request a Quote